18.04
1.59 (9.67%)
| Previous Close | 16.45 |
| Open | 16.47 |
| Volume | 436,924 |
| Avg. Volume (3M) | 452,298 |
| Market Cap | 801,927,424 |
| Price / Sales | 75.68 |
| Price / Book | 2.44 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2026 |
| Operating Margin (TTM) | -1,133.43% |
| Diluted EPS (TTM) | -1.98 |
| Total Debt/Equity (MRQ) | 3.29% |
| Current Ratio (MRQ) | 13.68 |
| Operating Cash Flow (TTM) | -53.21 M |
| Levered Free Cash Flow (TTM) | -34.85 M |
| Return on Assets (TTM) | -19.54% |
| Return on Equity (TTM) | -30.20% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Bullish | |
| Stock | BioAge Labs, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 4.0 |
| Average | 2.50 |
|
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| % Held by Insiders | 3.63% |
| % Held by Institutions | 66.65% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |